Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             18 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 2021 ASH annual meeting del Pozo Martín, Yaiza

9 2 p. e92-e93
artikel
2 Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group Raje, Noopur S

9 2 p. e143-e161
artikel
3 Correction to Lancet Haematol 2021; 8: e410–21
9 2 p. e91
artikel
4 From residency training to professional life: which competencies and skills are most valued by haematologists in Brazil? Barbosa, Ayla Cristina Nobrega

9 2 p. e95-e96
artikel
5 Individualised doses of anti-thymocyte globulin and immune recovery after allogeneic HSCT Baron, Frédéric

9 2 p. e84-e86
artikel
6 Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial Admiraal, Rick

9 2 p. e111-e120
artikel
7 KIR2DS1–HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials Kaddu-Mulindwa, Dominic

9 2 p. e133-e142
artikel
8 Lakshmi Nayak: striving to contain the brain's deadliest killers Cavanaugh, Ray

9 2 p. e97
artikel
9 Matchpoint: the game is not over for blast-phase chronic myeloid leukaemia Rousselot, Philippe

9 2 p. e86-e87
artikel
10 Melflufen for multiple myeloma: a promise unfulfilled? Kapoor, Prashant

9 2 p. e82-e84
artikel
11 Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study Schjesvold, Fredrik H

9 2 p. e98-e110
artikel
12 Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial Copland, Mhairi

9 2 p. e121-e132
artikel
13 Reporting of trials with possible detrimental overall survival: a patient advocate perspective Berger, Katherine

9 2 p. e94
artikel
14 Retinopathy associated with severe thrombocytopenia Kaspi, Mathilde

9 2 p. e166
artikel
15 Risk stratified management approaches for smouldering multiple myeloma: clinical research becomes clinical practice Lonial, Sagar

9 2 p. e162-e165
artikel
16 Thank you to our reviewers of 2021 The Editors of The Lancet Haematology,

9 2 p. e89-e90
artikel
17 The role of conferences in tackling inequalities The Lancet Haematology,

9 2 p. e81
artikel
18 Using immunogenetics to inform immunotherapy of lymphoid malignancies Vago, Luca

9 2 p. e88-e89
artikel
                             18 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring